The first-ever World Hepatitis Testing Week starts 18 November. Inspired by the European Testing Week, it is a global effort to encourage people to get tested for hepatitis B and hepatitis C.
The Take Home Naloxone (THN) program funds pharmacies to provide Naloxone free to people who use opioids or who know someone who does. Use these maps to find your nearest naloxone pharmacy.
South Australian MPs have been urged by Hepatitis SA and Cancer Council SA to help raise hepatitis B awareness in their communities
As Australia marks World Hepatitis Day on 28 July, we are reminded that almost 300,000 people in the country are living with hepatitis B or hepatitis C, putting them at increased risk of serious liver disease and liver cancer. They shouldn’t have to be. There is effective treatment and a vaccine for hepatitis B, and hepatitis C can be cured with highly effective direct-acting antivirals.
Update your knowledge about blood-safety and viral hepatitis with a free online education session from the Hep SA education team.
Health Minister Mark Butler has urged Australians to accelerate action to eliminate hepatitis B and hepatitis C. The Minister was at a federal parliamentary World Hepatitis Day event on 4 July 2024.
Reconciliation between Aboriginal and non-indigenous Australians took a battering in 2023 when the referendum on constitutional recognition of our country’s first people was defeated.
There's some welcome funding for the fight to eliminate viral hepatitis but it's disappointing to note that hepatitis B again gets a back seat.
The Fourth World Hepatitis Summit has called for a reset and re-invigoration of the world's response to hepatitis. Delivered at the close of the Summit on 11 April, the Declaration outlined three key steps:
According to the World Health Organization (WHO) 2024 Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing. The disease is the second leading infectious cause of death globally -- with 1.3 million deaths per year, the same as tuberculosis, a top infectious killer, second only to COVID-19.
Introducing HepSA Community News, the shared online space for our HepSAY blog and the quarterly Hepatitis SA Community News.
An innovative University of Sydney study is underway to explore whether paying someone a cash incentive would motivate them to start hepatitis C treatment, and if it does, what is the sweet spot. The study will also look at whether paying a GP to prescribe hepatitis C treatment will increase treatment initiation rate.
